$8.90
-0.05[-0.56%]
At close: Apr 18
$8.90
0[0.00%]
After Hours: 9:01AM EDT
Oncternal Therapeutics
(NASDAQ:ONCT)Oncternal Therapeutics Stock (NASDAQ:ONCT), Quotes and News Summary
Oncternal Therapeutics Stock (NASDAQ: ONCT) stock price, news, charts, stock research, profile.
| Open | $8.880 |
| Close | $8.600 |
| Volume / Avg. | 2.821K / 10.544K |
| Day Range | 8.131 - 8.880 |
| 52 Wk Range | 5.566 - 13.140 |
| Market Cap | $26.341M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 47 |
| Short Interest | 0.61% |
| Days to Cover | 2.56 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Oncternal Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel the...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Oncternal Therapeutics (ONCT) stock?
You can purchase shares of Oncternal Therapeutics (NASDAQ: ONCT) through any online brokerage.
Who are Oncternal Therapeutics's (ONCT) competitors?
Other companies in Oncternal Therapeutics’s space includes: NKGen Biotech (NASDAQ:NKGN), CERo Therapeutics Hldgs (NASDAQ:CERO), Serina Therapeutics (AMEX:SER), Acurx Pharmaceuticals (NASDAQ:ACXP) and Addex Therapeutics (NASDAQ:ADXN).
What is the target price for Oncternal Therapeutics (ONCT) stock?
The latest price target for Oncternal Therapeutics (NASDAQ: ONCT) was reported by HC Wainwright & Co. on Monday, April 15, 2024. The analyst firm set a price target for 28.00 expecting ONCT to rise to within 12 months (a possible 214.61% upside). 7 analyst firms have reported ratings in the last year.
Current Stock Price for Oncternal Therapeutics (ONCT)?
The stock price for Oncternal Therapeutics (NASDAQ: ONCT) is $8.9 last updated April 18, 2024 at 9:01 AM EDT.
Does Oncternal Therapeutics (ONCT) pay a dividend?
There are no upcoming dividends for Oncternal Therapeutics.
When is Oncternal Therapeutics (NASDAQ:ONCT) reporting earnings?
Oncternal Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.
Is Oncternal Therapeutics (ONCT) going to split?
There is no upcoming split for Oncternal Therapeutics.
What sector and industry does Oncternal Therapeutics (ONCT) operate in?
Oncternal Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.